WeVote

Bill

Bill

HB 395

AN ACT TO AMEND TITLES 3, 4, AND 16 OF THE DELAWARE CODE RELATING TO HEMP, MARIJUANA, AND MARIJUANA PRODUCTS.

153rd General Assembly (2025-2026) Introduced by Darius Brown and 4 co-sponsors

HB 395 updates Delaware’s hemp and marijuana laws, clarifying definitions, licensing, product rules, and public-safety provisions for hemp, cannabis products, and enforcement.

Assigned to Health & Social Services Committee in Senate
0
WeVote Research Nonpartisan
Bill Summary · HB 395

HB 395 (Delaware, 153rd Session)
Summary of Purpose, Provisions, and Impact

Overview
- Full title: AN ACT TO AMEND TITLES 3, 4, AND 16 OF THE DELAWARE CODE RELATING TO HEMP, MARIJUANA, AND MARIJUANA PRODUCTS.
- Purpose: To adjust the state's regulatory framework and enforcement around hemp, marijuana, and marijuana-derived products. The bill seeks to update definitions, licensing, permissible activities, and related public health and safety provisions within the agricultural, criminal code, and health regimes.
- Principal sponsors: Ed Osienski (lead) with cosponsors Stell Selby, Darius Brown, Russ Huxtable, and Nnamdi Chukwuocha.
- Committee history: Introduced 2026-04-30; initially assigned to the Economic Development/Banking/Insurance & Commerce Committee, then re-assigned to Health & Human Development Committee on the same day.

What the bill aims to change
While the exact text is not provided here, HB 395 typically would address:
- Hemp vs. marijuana definitions: Clarifying or updating statutory definitions to align with federal changes or state policy goals, including distinctions based on delta-9 tetrahydrocannabinol (THC) concentration.
- Licensing and regulation: Establishing or revising licensing requirements for growing, processing, distributing, or retailing hemp and marijuana products; potentially creating or modifying regulatory agencies or administrative processes.
- Product standards and labeling: Setting quality, safety, and labeling requirements for hemp-derived products (e.g., hemp flower, CBD products) and marijuana products; specifying permissible concentrations, packaging, and marketing restrictions.
- Edibles and products: Rules governing marijuana-infused products, dosage limits, child-resistance standards, and testing requirements.
- Public health and safety: Provisions related to driving under the influence, workplace safety, product recalls, and age restrictions for purchase.
- Tax and funding provisions: Possible changes to taxation framework for hemp vs. marijuana products and funding for regulatory agencies or enforcement.
- Criminal penalties and enforcement: Adjustments to penalties for unlawful distribution, possession amounts, or illicit production; enhanced enforcement provisions or compliance timelines.

Who would be affected
- Hemp industry participants: Farmers, processors, distributors, and retailers dealing with hemp-derived products; licensing and compliance obligations may apply or expand.
- Marijuana/marijuana product sector: Cannabis cultivators, manufacturers, retailers, and on-site consumption venues would be subject to updated licensing, testing, labeling, and age-restriction rules.
- Consumers: Public health protections, product labeling, age verification, and safety standards aim to improve consumer safety.
- Law enforcement and judiciary: Potential changes in enforcement priorities, offense classifications, and penalties; updated training and compliance expectations.
- State agencies: Likely involvement from departments overseeing agriculture, health, revenue/tax, and justice, including potential new or reorganized regulatory responsibilities.

Key procedural and timeline aspects
- Legislative process: After introduction, the bill is assigned to a standing committee (initially Economic Development/Banking/Insurance & Commerce, then moved to Health & Human Development). Hearings, amendments, and potential floor votes would occur in committee and chamber.
- Implementation timelines: If enacted, the bill would specify effective dates for new definitions, licensing regimes, and compliance deadlines (e.g., phased implementation for licenses, product recalls, or testing requirements). Look for explicit dates in the final text (e.g., “effective 180 days after enactment” or “phased compliance beginning YYYY-MM-DD”).

Notes for readers
- The bill’s actual text will define precise changes to Titles 3 (Agriculture), 4 ( Agriculture and Domestic Animals; restrictions may relate to hemp processing or licensing), and 16 (Crimes and Punishments), which will determine the exact regulatory shifts, licensing structures, and penalties.
- For stakeholders, it is important to track committee hearings and any amendments, as these can alter licensing thresholds, product definitions (e.g., THC limits), and enforcement mechanisms.

Recommendation
- Review the official bill text and fiscal notes once available to understand exact THC thresholds, licensing timelines, and any tax or fund implications. Monitor committee schedules for the Health & Human Development Committee to anticipate public hearings and opportunities to provide testimony.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.